Immunosuppressive Agents and CMV Risk in the VICTOR Study

Post‐hoc analysis of the VICTOR trial data concerning immunosuppressive agents yields some anticipated and some unexpected results.
See Article by Åsberg et al on page 1881.

Saved in:
Bibliographic Details
Published in:American journal of transplantation 2010-08, Vol.10 (8), p.1727-1728
Main Authors: Avery, R. K., Kaplan, B.
Format: Article
Language:English
Subjects:
Cytomegalovirus Infections - prevention & control
Ganciclovir - analogs & derivatives
Ganciclovir - therapeutic use
Humans
Immunosuppressive Agents - therapeutic use
Organ Transplantation - methods
Randomized Controlled Trials as Topic
Valganciclovir
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Post‐hoc analysis of the VICTOR trial data concerning immunosuppressive agents yields some anticipated and some unexpected results.
See Article by Åsberg et al on page 1881.
ISSN:1600-6135
1600-6143
DOI:10.1111/j.1600-6143.2010.03194.x